AdhereTech Smart Pill Bottle
Connected medication adherence solution with real-time monitoring and patient engagement
Company profile
Company profile
AdhereTech is a healthcare technology company specializing in medication adherence solutions for the pharmaceutical and healthcare industries. The company develops smart pill bottles equipped with cellular connectivity and sensor technology that automatically track medication usage in real-time. These connected devices integrate with AdhereTech's AI-powered patient engagement platform to deliver personalized interventions including automated reminders, educational content, and behavioral nudges designed to improve medication adherence rates. AdhereTech's solutions are primarily deployed in specialty pharmacy settings, clinical trials, and pharmaceutical patient support programs where medication adherence is critical to treatment success and patient outcomes. The company serves pharmaceutical manufacturers, specialty pharmacies, health systems, and research organizations seeking to reduce non-adherence, improve clinical outcomes, and generate real-world evidence on medication usage patterns. AdhereTech's platform combines hardware innovation with data analytics and machine learning to identify at-risk patients and trigger timely interventions, helping healthcare stakeholders address the significant clinical and economic burden of medication non-adherence.
Company description AdhereTech official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Embedded deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Connected medication adherence solution with real-time monitoring and patient engagement
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of acquired immune deficiency syndromes (1999) · Jan 1, 2021
Clinical validation
NCT03708731 · Mentioned · ACTIVE NOT RECRUITING
Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)NCT04114669 · Mentioned · COMPLETED
Epilepsy Adherence in Children and Technology (eACT)NCT03817229 · Mentioned · COMPLETED
A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid LeukemiaNCT04694820 · Mentioned · COMPLETED
Mobile Intervention to Improve Adherence of Oral Anti-cancer Medications Among Acute Myeloid Leukemia Patients, the txt4AML StudyNCT05595135 · Mentioned · WITHDRAWN
Improve Glaucoma Medication AdherenceNCT03052257 · Mentioned · COMPLETED
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
through automated tracking and personalized interventions
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on AdhereTech's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI for medication optimization, pharmacy automation, drug pricing and access, medication adherence, polypharmacy management, or pharmacy workflow optimization. Includes platforms that help patients access affordable medications, tools that reduce medication errors, and AI systems that optimize drug regimens for complex patients.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.